Literature DB >> 2685383

Antibody testing in Lyme disease. A comparison of results in four laboratories.

B S Schwartz1, M D Goldstein, J M Ribeiro, T L Schulze, S I Shahied.   

Abstract

To evaluate the interlaboratory and intralaboratory agreement in the performance of Lyme disease serological testing, we sent serum specimens from 132 outdoor workers in New Jersey to as many as four independent laboratories. These included one state department of health laboratory, one large commercial laboratory, and two research laboratories. The measurement of agreement employed, the kappa statistic, ranged from .45 to .53 among the four laboratories and from .50 to .54 within the commercial laboratory. These values represent low levels of agreement. The data suggest that Lyme disease serological testing procedures should be standardized so that Lyme disease test results are more comparable between laboratories.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2685383

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

1.  Intra- and interlaboratory reproducibility of an ELISA serological test for Lyme disease.

Authors:  M C Tammemagi; J W Frank; M Leblanc; H Artsob
Journal:  Can J Infect Dis       Date:  1995-03

2.  Quality control assessment of Canadian laboratories testing for Lyme disease.

Authors:  H Artsob; M Garvie
Journal:  Can J Infect Dis       Date:  1991

3.  Lyme disease surveillance in California.

Authors:  R Werra
Journal:  West J Med       Date:  1991-02

Review 4.  Lyme disease.

Authors:  D W Rahn; S E Malawista
Journal:  West J Med       Date:  1991-06

5.  Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing Program.

Authors:  L L Bakken; S M Callister; P J Wand; R F Schell
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

6.  Interlaboratory comparison of titers of antibody to Borrelia burgdorferi and evaluation of a commercial assay using canine sera.

Authors:  R T Greene; D A Hirsch; P L Rottman; T M Gerig
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

7.  Atypical bilateral symmetric erosive chronic polyarthritis in the course of Lyme disease.

Authors:  J Gutiérrez; M Palermo; M C Maroto; M Abellan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

8.  Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting.

Authors:  J R Creson; L C Lim; N J Glowacki; S M Callister; R F Schell
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

9.  Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation.

Authors:  R B Craven; T J Quan; R E Bailey; R Dattwyler; R W Ryan; L H Sigal; A C Steere; B Sullivan; B J Johnson; D T Dennis; D J Gubler
Journal:  Emerg Infect Dis       Date:  1996 Apr-Jun       Impact factor: 6.883

10.  Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspA, fla, HSP60, and HSP70 gene probes.

Authors:  R Wallich; C Helmes; U E Schaible; Y Lobet; S E Moter; M D Kramer; M M Simon
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.